UPMC Health Plan · Zepbound and Wegovy coverage

Does UPMC Health Plan cover Zepbound or Wegovy?

Last updated

Not for most Pennsylvania commercial plans, by its January 2025 update.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Not for most Pennsylvania commercial plans, by its January 2025 update. UPMC's January 2025 provider update says Wegovy, Zepbound and Saxenda for overweight or obesity are not covered for its individual, small-group and most large-group commercial patients in Pennsylvania. In its words: "Saxenda, Wegovy (when used for overweight/obesity), and Zepbound are currently ineligible for coverage for all Medicare and SNP patients in the country, CHIP, and individual/small-group Commercial patients in Pennsylvania, and most large-group UPMC Health Plan Commercial patients." (UPMC Health Plan Provider Partner Update, January 2025, upmchealthplan.com, read Nov 19, 2026). UPMC's June 2026 notice says the federal Medicare GLP-1 Bridge, starting July 1, 2026, is for eligible Medicare Part D members using GLP-1 medications to reduce excess body weight. In its words: "This program is for eligible Medicare Part D beneficiaries using GLP-1 medications for the sole purpose of reducing excess body weight and maintaining weight reduction." (UPMC Health Plan provider announcement, Important information regarding Medicare GLP-1 Bridge, June 2026, upmchealthplan.com, read Nov 19, 2026).

Questions

UPMC Health Plan, Zepbound and Wegovy: common questions

Does UPMC Health Plan cover Zepbound for weight loss?

Not for most Pennsylvania commercial plans, by its January 2025 update. UPMC's January 2025 provider update says Wegovy, Zepbound and Saxenda for overweight or obesity are not covered for its individual, small-group and most large-group commercial patients in Pennsylvania. In its words: "Saxenda, Wegovy (when used for overweight/obesity), and Zepbound are currently ineligible for coverage for all Medicare and SNP patients in the country, CHIP, and individual/small-group Commercial patients in Pennsylvania, and most large-group UPMC Health Plan Commercial patients." (UPMC Health Plan Provider Partner Update, January 2025, upmchealthplan.com, read Nov 19, 2026). UPMC's June 2026 notice says the federal Medicare GLP-1 Bridge, starting July 1, 2026, is for eligible Medicare Part D members using GLP-1 medications to reduce excess body weight. In its words: "This program is for eligible Medicare Part D beneficiaries using GLP-1 medications for the sole purpose of reducing excess body weight and maintaining weight reduction." (UPMC Health Plan provider announcement, Important information regarding Medicare GLP-1 Bridge, June 2026, upmchealthplan.com, read Nov 19, 2026). Zepbound not covered: the cash price at your dose

Does UPMC Health Plan cover Wegovy for weight loss?

Not for most Pennsylvania commercial plans, by its January 2025 update. UPMC's January 2025 provider update says Wegovy, Zepbound and Saxenda for overweight or obesity are not covered for its individual, small-group and most large-group commercial patients in Pennsylvania. In its words: "Saxenda, Wegovy (when used for overweight/obesity), and Zepbound are currently ineligible for coverage for all Medicare and SNP patients in the country, CHIP, and individual/small-group Commercial patients in Pennsylvania, and most large-group UPMC Health Plan Commercial patients." (UPMC Health Plan Provider Partner Update, January 2025, upmchealthplan.com, read Nov 19, 2026). UPMC's June 2026 notice says the federal Medicare GLP-1 Bridge, starting July 1, 2026, is for eligible Medicare Part D members using GLP-1 medications to reduce excess body weight. In its words: "This program is for eligible Medicare Part D beneficiaries using GLP-1 medications for the sole purpose of reducing excess body weight and maintaining weight reduction." (UPMC Health Plan provider announcement, Important information regarding Medicare GLP-1 Bridge, June 2026, upmchealthplan.com, read Nov 19, 2026). Wegovy not covered: the cash price at your dose

Is UPMC Health Plan dropping GLP-1 coverage for weight loss?

Not for most Pennsylvania commercial plans, by its January 2025 update. UPMC's June 2026 notice says the federal Medicare GLP-1 Bridge, starting July 1, 2026, is for eligible Medicare Part D members using GLP-1 medications to reduce excess body weight. In its words: "This program is for eligible Medicare Part D beneficiaries using GLP-1 medications for the sole purpose of reducing excess body weight and maintaining weight reduction." (UPMC Health Plan provider announcement, Important information regarding Medicare GLP-1 Bridge, June 2026, upmchealthplan.com, read Nov 19, 2026).

What do Zepbound and Wegovy cost if UPMC Health Plan does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership) among sellers that serve Pennsylvania; compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership) among sellers that serve Pennsylvania. Every GLP-1's cash price without insurance

Does Medicaid cover Zepbound or Wegovy?

It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.